Trade Name | Drug | Strength | Company | Expiry | Exclusivity |
---|
FDA market exclusivity is an incentive granted by the FDA and differs from patent exclusivity.
Drug exclusivities include, Orphan Drug Exclusivity (ODE) – 7 years, New Chemical Entity Exclusivity (NCE) – 5 years, Generating Antibiotic Incentives Now (GAIN) Exclusivity– 5 years added to certain exclusivities, New Clinical Investigation Exclusivity – 3 years, Pediatric Exclusivity (PED) – 6 months added to existing Patents/Exclusivity, Patent Challenge (PC) – 180 days (this exclusivity is for ANDAs only), Competitive Generic Therapy (CGT) - 180 days (this exclusivity is for ANDAs only).
Often there is the option for patent holders to seek pediatric exclusivity which often requires additional work. In return for the pediatric work 6 months exclusivity is added to the all existing patents on that product.
Search Drug Patents